Respiratory support, surface activity and protein content during nosocomial infection in preterm neonates

Neonatology

Volumn 70, Issue 5, 1996, Pages 271-279

  Griese, Matthias ^a   Westerburg, Bettina ^a   Potz, Christiane ^a   Dietrich, Petra ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adult respiratory distress syndrome; Nosocomial infection; Pulsating bubble surfactometer; Small preterm neonates; Staphylococcus epidermidis; Subfractions; Surface activity; Surfactant function

Indexed keywords

ALBUMIN; LUNG SURFACTANT; PROTEIN;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CENTRIFUGATION; CLINICAL ARTICLE; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS SURFACE TENSION; LUNG LAVAGE; NEWBORN; OXYGENATION; PREMATURITY; PRIORITY JOURNAL; PROTEIN CONTENT; SURFACE TENSION;

ADSORPTION; BRONCHOALVEOLAR LAVAGE FLUID; CALCIUM; CROSS INFECTION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROTEINS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; SURFACE TENSION; TIME FACTORS;

STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0029857793     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244376     Document Type: Article

References (32)

1. Hall SL: Coagulase-ncgative staphylococcal infections in neonates. Pediatr Infect DisJ 1991;10:57-67.
2. Noel GJ, Edelson PJ: Staphylococcus epidermidis bacteremia in neonates: Further observations and the occurrence of focal infection. Pediatrics 1984;74:832-837.
3. Schmidt BK, Kirpalani HM, Corey M: Coagulase-negative staphylococci as true pathogcnes in newborn infants: A cohort study. Pediatr Infect DisJ 1987:6:1026-1031.
4. Brogden KA: Changes in pulmonary surfactant during bacterial pneumonia. Antonia Van Leeuwenhoek 1991;59:215-223.
5. Baughman RP, Stein E, MacGee J, Rashkin M, Sahebjami H: Changes in fatty acids in phospholipids of bronchoalvcolar fluid in bacterial pneumonia and in adult respiratory distress syndrome. Clin Chcm 1984: 30:521-523.
6. King RJ, Coalson JJ, Scidenfeld JJ, Anzucto AR, Smith DB, Peters JI: Oi- and pneumonia-induced lung injury. II. Properties of pulmonary surfactant. J Appl Physiol 1989:67: 357-365.
7. Sachse K: Changes in the relative concentrations of surfactant phospholipids in young pigs with experimental pneumonia. J Vet Med 1989:36:385-390.
8. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L: Evidence of lungsurfactant abnormality in respiratory failure. Study of bronchoal-veolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982:70:673-683.
9. Rose M, Lindberg DAB: Effect of pulmonary pathogens on surfactant. Dis Chest 1986:53:541-544.
10. Thavanainen J, Hallman M: Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs. Eur Respir J 1987;71:250-258.
11. Lewis JF, Jobe AH: Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147:218-233.
12. Gricse M, Dietrich P, Potts C, Westerburg B, Bals R, Reinhardt D: Surfactant inffractions during nosocomial infection in ventilated preterm human neonates. Am J Respir Crit Care Med 1996:153:398-403.
13. King RJ, Coalson JJ, deLemos RA, Gerstmann DR. Seidncr SR: Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995;151:1989-1997.
14. Holm BA: Surfactant inactivation in adult respiratory distress syndrome: in Robertson B, Van Golde LMG, Batenburg JJ (eds): Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam. Elsevier, 1992. pp 665-684.
15. Gricse M, Westerburg B, Dietrich P, Potts C, Reinhardt D: Surface activity of airway secretions from ventilated neonates with nosocomial infection (abstract). Am J Respir Crit Care Med 1995:151:745.
16. Lewis JF, Ikegami M, Jobe AH: Metabolism of exogenously administered surfactant in the acutly injured lungs of adult rabbits. Am Rev Respir Dis 1992;145:19-23.
17. Vcldhuizen RAW, Inchley K, Hearn SA. Lewis JF, Possmaycr JF: Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 1993:295:141-147.
18. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
19. Sachs L: Statistische Methoden, ed 4. Berlin, Springer, 1979.
20. Ikegami M, Jacobs H, Jobe A: Surfactant function in respiratory distress syndrome. J Pediatr 1983:102: 443-447.
21. Griese M, Westerburg B, Roos R, Reinhardt D: Anderung der mi-nimalcn Oberflachenspannung im Lungenspiilwasscr von beatmcten Friihgeborenen mil und ohne Sur-factantherapie. Monatsschr Kin-derheilk 1993:141:18.
22. Griese M, Dietrich P, Reinhardt D: Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1050-1054.
23. Avery ME, Mead J: Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959:97:517-523.
24. Gruenwald P, Johnson RP, Hustead RF, Clements JA: Correlation of mechanical properties of infants lungs with surface activity of extracts. Proc Soc Exp Biol Med 1962; 109:369-371.
25. Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertackc U, Ncuhof H, Schmidt-Ncuenburg KP: Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989:140:1033-1139.
26. Spragg RG, Gillard N, Richman P, Smith RM, Hite D, Pappert D, Heldt GP, Merrit TA: The adult respiratory distress syndrome: Clinical aspects relevant to surfactant supplementation: in Robertson B, Van Golde LMG, Batenburg JJ (eds): Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam. Elsevier. 1992. pp 685-704.
27. Gunther A, Sicbcrt C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996:153:176-184.
28. Amirkhanian JD, Bruni R, Waring AJ, Taeusch HW: Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C. Biochim Bio-physActa 1991;1096:355-360.
29. Coalson JJ, King RJ, Yang F, Winter V, Whitsett JA, deLemos RA, Seidner SR: SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. Am J Respir Crit Care Med 1995:151:854-866.
30. Seeger W, Grube C, Gunther A, Schmidt R: Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur Respir J 1993;6:971-977.
31. Suzuki Y: Effect of protein, cholesterol. and phosphatidylglycerol on the surface activity of the lipid-pro-tein complex reconstituted from pig pulmonary surfactant. J Lipid Res 1982;23:62-69.
32. Hallman M, Merrit TA, Akino T, Bry K: Surfactant protein A. phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Am Rev Respir Dis 1991; 144:1376-1384.